|
(11) | EP 1 058 551 A1 |
(12) |
|
|
|
|
|||||||||||||||||||||||
(54) | USE OF D1/D5 ANTAGONISTS FOR TREATING OBSESSIVE COMPULSIVE DISORDERS, SOMATOFORM DISORDERS, DISSOCIATIVE DISORDERS, EATING DISORDERS, IMPULSE CONTROL DISORDERS AND AUTISM |